RT Book, Section
A1 Wood, Sarah M.
A1 Rutstein, Richard M.
A1 Steenhoff, Andrew P.
A2 Shah, Samir S.
SR Print(0)
ID 6911114
T1 Chapter 52. HIV-Exposed Neonate and HIV At-Risk Child
T2 Pediatric Practice: Infectious Disease
YR 2009
FD 2009
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-148924-9
LK accesspediatrics.mhmedical.com/content.aspx?aid=6911114
RD 2024/04/18
AB Worldwide,  more  than  2  million  children  younger  than  15  years  are  infected  with  HIV,  with  perinatal  transmission  the  source  of  most  of  these  infections.1,2  In  the  developed  world,  where  prenatal  testing  and  safe  and  effective  antiretroviral  prophylaxis  are  widely  available,  perinatally-acquired  HIV  has  become  almost  entirely  preventable.  With  early  testing  and  treatment  of  HIV-infected  mothers  and  their  newborns  the  risk  of  perinatal  HIV  transmission  can  be  reduced  to  less  than  2%.3  The  pediatric  provider  plays  an  essential  role  in  disease  reduction.  By  early  identification  of  HIV-exposed  infants,  timely  virologic  testing  and  provision  of  postpartum  HIV  and  opportunistic  infection  prophylaxis,  pediatric  care  providers  can  intervene  to  dramatically  reduce  the  risk  of  infection  for  the  neonate.